Description
Semax is a synthetic heptapeptide derived from a fragment of the adrenocorticotropic hormone (ACTH 4-10) sequence. It has been characterized in preclinical research as a neuropeptide that interacts with melanocortin and BDNF-related signaling pathways, making it a frequently used tool compound for investigating neuromodulatory endpoints in experimental designs.
Semax has been examined in preclinical in vitro and rodent model studies of neurotrophic factor expression, neuroprotection under ischemic conditions, cognitive and attention-related behavioral paradigms, and stress-axis signaling. Its liquid spray formulation supports time-course and bioavailability investigations in laboratory research settings.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.